An analysis of data from 41 health care systems participating in the National Patient-Centered Clinical Research Network found lower use of monoclonal antibody therapies for patients who are Black, Asian or other races compared with white and non-Hispanic patients between November 2020 and August 2021, the Centers for Disease Control and Prevention reported Friday. Among all patients with positive SARS-CoV-2 test results, the overall use of mAb was infrequent, with mean monthly use at 4% or less for all racial and ethnic groups.

In other news, the CDC Friday released updated COVID-19 masking information for consumers to reflect the latest science. The update lays out the protection provided by available masks and respirators, noting that some provide better protection than others.

Related News Articles

Headline
A recent op-ed in the online publication STAT contains “blatant factual inaccuracies” and omits critical information about hospital and health systems’…
Headline
Hospital and health system leaders focused on health equity and/or diversity and inclusion initiatives in their organizations are encouraged to complete the…
Headline
The Health Resources and Services Administration yesterday released another $450 million in American Rescue Plan Act payments to rural health care providers to…
Headline
AHA today launched a new suite of resources for rural health care leaders, including an on-demand webinar and playbook. The webinar features rural hospital…
Chairperson's File
It was great to connect with so many colleagues last week at the AHA Annual Membership Meeting in Washington, D.C. One of my priorities as chair is to keep…
Headline
AHA and its Institute for Diversity and Health Equity announced that members should complete the biennial diversity and health equity benchmark survey no later…